TrialTrials2013

WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial.

Daniel Hofmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.